Global Opioid Analgesics Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
According to our (Global Info Research) latest study, the global Opioid Analgesics market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Opioid Analgesics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2022, are provided.
Key Features:
Global Opioid Analgesics market size and forecasts, in consumption value ($ Million), sales quantity (K Tons), and average selling prices (US$/Ton), 2017-2028
Global Opioid Analgesics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Tons), and average selling prices (US$/Ton), 2017-2028
Global Opioid Analgesics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Tons), and average selling prices (US$/Ton), 2017-2028
Global Opioid Analgesics market shares of main players, shipments in revenue ($ Million), sales quantity (K Tons), and ASP (US$/Ton), 2017-2022
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Opioid Analgesics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Opioid Analgesics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc., Abbott Laboratories, Johnson & Johnson, Novartis AG and Bayer AG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Opioid Analgesics market is split by Type and by Application. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Opioid Analgesics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Opioid Analgesics, with price, sales, revenue and global market share of Opioid Analgesics from 2017 to 2022.
Chapter 3, the Opioid Analgesics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioid Analgesics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Opioid Analgesics market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Opioid Analgesics.
Chapter 14 and 15, to describe Opioid Analgesics sales channel, distributors, customers, research findings and conclusion.
This report is a detailed and comprehensive analysis for global Opioid Analgesics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2022, are provided.
Key Features:
Global Opioid Analgesics market size and forecasts, in consumption value ($ Million), sales quantity (K Tons), and average selling prices (US$/Ton), 2017-2028
Global Opioid Analgesics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Tons), and average selling prices (US$/Ton), 2017-2028
Global Opioid Analgesics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Tons), and average selling prices (US$/Ton), 2017-2028
Global Opioid Analgesics market shares of main players, shipments in revenue ($ Million), sales quantity (K Tons), and ASP (US$/Ton), 2017-2022
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Opioid Analgesics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Opioid Analgesics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc., Abbott Laboratories, Johnson & Johnson, Novartis AG and Bayer AG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Opioid Analgesics market is split by Type and by Application. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- OxyContin
- Vicodin
- Morphine
- Methadone
- Others
- Surgical Pain
- Cancer Pain
- Neuropathic Pain
- Others
- Pfizer Inc.
- Abbott Laboratories
- Johnson & Johnson
- Novartis AG
- Bayer AG
- GlaxoSmithKline plc
- F. Hoffmann-La Roche AG
- Boehringer Ingelheim International GmbH
- Bausch Health
- Sanofi S.A.
- Teva Pharmaceuticals
- Purdue Pharmaceuticals L.P.
- Endo International Plc
- Assertio Holdings, Inc
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Opioid Analgesics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Opioid Analgesics, with price, sales, revenue and global market share of Opioid Analgesics from 2017 to 2022.
Chapter 3, the Opioid Analgesics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioid Analgesics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Opioid Analgesics market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Opioid Analgesics.
Chapter 14 and 15, to describe Opioid Analgesics sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Opioid Analgesics Introduction
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Opioid Analgesics Consumption Value by Type: 2017 Versus 2021 Versus 2028
1.3.2 OxyContin
1.3.3 Vicodin
1.3.4 Morphine
1.3.5 Methadone
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Opioid Analgesics Consumption Value by Application: 2017 Versus 2021 Versus 2028
1.4.2 Surgical Pain
1.4.3 Cancer Pain
1.4.4 Neuropathic Pain
1.4.5 Others
1.5 Global Opioid Analgesics Market Size & Forecast
1.5.1 Global Opioid Analgesics Consumption Value (2017 & 2021 & 2028)
1.5.2 Global Opioid Analgesics Sales Quantity (2017-2028)
1.5.3 Global Opioid Analgesics Average Price (2017-2028)
2 MANUFACTURERS PROFILES
2.1 Pfizer Inc.
2.1.1 Pfizer Inc. Details
2.1.2 Pfizer Inc. Major Business
2.1.3 Pfizer Inc. Opioid Analgesics Product and Services
2.1.4 Pfizer Inc. Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.1.5 Pfizer Inc. Recent Developments/Updates
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Opioid Analgesics Product and Services
2.2.4 Abbott Laboratories Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.2.5 Abbott Laboratories Recent Developments/Updates
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Opioid Analgesics Product and Services
2.3.4 Johnson & Johnson Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.3.5 Johnson & Johnson Recent Developments/Updates
2.4 Novartis AG
2.4.1 Novartis AG Details
2.4.2 Novartis AG Major Business
2.4.3 Novartis AG Opioid Analgesics Product and Services
2.4.4 Novartis AG Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.4.5 Novartis AG Recent Developments/Updates
2.5 Bayer AG
2.5.1 Bayer AG Details
2.5.2 Bayer AG Major Business
2.5.3 Bayer AG Opioid Analgesics Product and Services
2.5.4 Bayer AG Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.5.5 Bayer AG Recent Developments/Updates
2.6 GlaxoSmithKline plc
2.6.1 GlaxoSmithKline plc Details
2.6.2 GlaxoSmithKline plc Major Business
2.6.3 GlaxoSmithKline plc Opioid Analgesics Product and Services
2.6.4 GlaxoSmithKline plc Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.6.5 GlaxoSmithKline plc Recent Developments/Updates
2.7 F. Hoffmann-La Roche AG
2.7.1 F. Hoffmann-La Roche AG Details
2.7.2 F. Hoffmann-La Roche AG Major Business
2.7.3 F. Hoffmann-La Roche AG Opioid Analgesics Product and Services
2.7.4 F. Hoffmann-La Roche AG Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.7.5 F. Hoffmann-La Roche AG Recent Developments/Updates
2.8 Boehringer Ingelheim International GmbH
2.8.1 Boehringer Ingelheim International GmbH Details
2.8.2 Boehringer Ingelheim International GmbH Major Business
2.8.3 Boehringer Ingelheim International GmbH Opioid Analgesics Product and Services
2.8.4 Boehringer Ingelheim International GmbH Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.8.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
2.9 Bausch Health
2.9.1 Bausch Health Details
2.9.2 Bausch Health Major Business
2.9.3 Bausch Health Opioid Analgesics Product and Services
2.9.4 Bausch Health Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.9.5 Bausch Health Recent Developments/Updates
2.10 Sanofi S.A.
2.10.1 Sanofi S.A. Details
2.10.2 Sanofi S.A. Major Business
2.10.3 Sanofi S.A. Opioid Analgesics Product and Services
2.10.4 Sanofi S.A. Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.10.5 Sanofi S.A. Recent Developments/Updates
2.11 Teva Pharmaceuticals
2.11.1 Teva Pharmaceuticals Details
2.11.2 Teva Pharmaceuticals Major Business
2.11.3 Teva Pharmaceuticals Opioid Analgesics Product and Services
2.11.4 Teva Pharmaceuticals Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.11.5 Teva Pharmaceuticals Recent Developments/Updates
2.12 Purdue Pharmaceuticals L.P.
2.12.1 Purdue Pharmaceuticals L.P. Details
2.12.2 Purdue Pharmaceuticals L.P. Major Business
2.12.3 Purdue Pharmaceuticals L.P. Opioid Analgesics Product and Services
2.12.4 Purdue Pharmaceuticals L.P. Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.12.5 Purdue Pharmaceuticals L.P. Recent Developments/Updates
2.13 Endo International Plc
2.13.1 Endo International Plc Details
2.13.2 Endo International Plc Major Business
2.13.3 Endo International Plc Opioid Analgesics Product and Services
2.13.4 Endo International Plc Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.13.5 Endo International Plc Recent Developments/Updates
2.14 Assertio Holdings, Inc
2.14.1 Assertio Holdings, Inc Details
2.14.2 Assertio Holdings, Inc Major Business
2.14.3 Assertio Holdings, Inc Opioid Analgesics Product and Services
2.14.4 Assertio Holdings, Inc Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.14.5 Assertio Holdings, Inc Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: OPIOID ANALGESICS BY MANUFACTURER
3.1 Global Opioid Analgesics Sales Quantity by Manufacturer (2017-2022)
3.2 Global Opioid Analgesics Revenue by Manufacturer (2017-2022)
3.3 Global Opioid Analgesics Average Price by Manufacturer (2017-2022)
3.4 Market Share Analysis (2021)
3.4.1 Producer Shipments of Opioid Analgesics by Manufacturer Revenue ($MM) and Market Share (%): 2021
3.4.2 Top 3 Opioid Analgesics Manufacturer Market Share in 2021
3.4.2 Top 6 Opioid Analgesics Manufacturer Market Share in 2021
3.5 Opioid Analgesics Market: Overall Company Footprint Analysis
3.5.1 Opioid Analgesics Market: Region Footprint
3.5.2 Opioid Analgesics Market: Company Product Type Footprint
3.5.3 Opioid Analgesics Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Opioid Analgesics Market Size by Region
4.1.1 Global Opioid Analgesics Sales Quantity by Region (2017-2028)
4.1.2 Global Opioid Analgesics Consumption Value by Region (2017-2028)
4.1.3 Global Opioid Analgesics Average Price by Region (2017-2028)
4.2 North America Opioid Analgesics Consumption Value (2017-2028)
4.3 Europe Opioid Analgesics Consumption Value (2017-2028)
4.4 Asia-Pacific Opioid Analgesics Consumption Value (2017-2028)
4.5 South America Opioid Analgesics Consumption Value (2017-2028)
4.6 Middle East and Africa Opioid Analgesics Consumption Value (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global Opioid Analgesics Sales Quantity by Type (2017-2028)
5.2 Global Opioid Analgesics Consumption Value by Type (2017-2028)
5.3 Global Opioid Analgesics Average Price by Type (2017-2028)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Opioid Analgesics Sales Quantity by Application (2017-2028)
6.2 Global Opioid Analgesics Consumption Value by Application (2017-2028)
6.3 Global Opioid Analgesics Average Price by Application (2017-2028)
7 NORTH AMERICA
7.1 North America Opioid Analgesics Sales Quantity by Type (2017-2028)
7.2 North America Opioid Analgesics Sales Quantity by Application (2017-2028)
7.3 North America Opioid Analgesics Market Size by Country
7.3.1 North America Opioid Analgesics Sales Quantity by Country (2017-2028)
7.3.2 North America Opioid Analgesics Consumption Value by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE
8.1 Europe Opioid Analgesics Sales Quantity by Type (2017-2028)
8.2 Europe Opioid Analgesics Sales Quantity by Application (2017-2028)
8.3 Europe Opioid Analgesics Market Size by Country
8.3.1 Europe Opioid Analgesics Sales Quantity by Country (2017-2028)
8.3.2 Europe Opioid Analgesics Consumption Value by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC
9.1 Asia-Pacific Opioid Analgesics Sales Quantity by Type (2017-2028)
9.2 Asia-Pacific Opioid Analgesics Sales Quantity by Application (2017-2028)
9.3 Asia-Pacific Opioid Analgesics Market Size by Region
9.3.1 Asia-Pacific Opioid Analgesics Sales Quantity by Region (2017-2028)
9.3.2 Asia-Pacific Opioid Analgesics Consumption Value by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA
10.1 South America Opioid Analgesics Sales Quantity by Type (2017-2028)
10.2 South America Opioid Analgesics Sales Quantity by Application (2017-2028)
10.3 South America Opioid Analgesics Market Size by Country
10.3.1 South America Opioid Analgesics Sales Quantity by Country (2017-2028)
10.3.2 South America Opioid Analgesics Consumption Value by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Opioid Analgesics Sales Quantity by Type (2017-2028)
11.2 Middle East & Africa Opioid Analgesics Sales Quantity by Application (2017-2028)
11.3 Middle East & Africa Opioid Analgesics Market Size by Country
11.3.1 Middle East & Africa Opioid Analgesics Sales Quantity by Country (2017-2028)
11.3.2 Middle East & Africa Opioid Analgesics Consumption Value by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 MARKET DYNAMICS
12.1 Opioid Analgesics Market Drivers
12.2 Opioid Analgesics Market Restraints
12.3 Opioid Analgesics Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Opioid Analgesics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Opioid Analgesics
13.3 Opioid Analgesics Production Process
13.4 Opioid Analgesics Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Opioid Analgesics Typical Distributors
14.3 Opioid Analgesics Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Opioid Analgesics Introduction
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Opioid Analgesics Consumption Value by Type: 2017 Versus 2021 Versus 2028
1.3.2 OxyContin
1.3.3 Vicodin
1.3.4 Morphine
1.3.5 Methadone
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Opioid Analgesics Consumption Value by Application: 2017 Versus 2021 Versus 2028
1.4.2 Surgical Pain
1.4.3 Cancer Pain
1.4.4 Neuropathic Pain
1.4.5 Others
1.5 Global Opioid Analgesics Market Size & Forecast
1.5.1 Global Opioid Analgesics Consumption Value (2017 & 2021 & 2028)
1.5.2 Global Opioid Analgesics Sales Quantity (2017-2028)
1.5.3 Global Opioid Analgesics Average Price (2017-2028)
2 MANUFACTURERS PROFILES
2.1 Pfizer Inc.
2.1.1 Pfizer Inc. Details
2.1.2 Pfizer Inc. Major Business
2.1.3 Pfizer Inc. Opioid Analgesics Product and Services
2.1.4 Pfizer Inc. Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.1.5 Pfizer Inc. Recent Developments/Updates
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Opioid Analgesics Product and Services
2.2.4 Abbott Laboratories Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.2.5 Abbott Laboratories Recent Developments/Updates
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Opioid Analgesics Product and Services
2.3.4 Johnson & Johnson Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.3.5 Johnson & Johnson Recent Developments/Updates
2.4 Novartis AG
2.4.1 Novartis AG Details
2.4.2 Novartis AG Major Business
2.4.3 Novartis AG Opioid Analgesics Product and Services
2.4.4 Novartis AG Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.4.5 Novartis AG Recent Developments/Updates
2.5 Bayer AG
2.5.1 Bayer AG Details
2.5.2 Bayer AG Major Business
2.5.3 Bayer AG Opioid Analgesics Product and Services
2.5.4 Bayer AG Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.5.5 Bayer AG Recent Developments/Updates
2.6 GlaxoSmithKline plc
2.6.1 GlaxoSmithKline plc Details
2.6.2 GlaxoSmithKline plc Major Business
2.6.3 GlaxoSmithKline plc Opioid Analgesics Product and Services
2.6.4 GlaxoSmithKline plc Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.6.5 GlaxoSmithKline plc Recent Developments/Updates
2.7 F. Hoffmann-La Roche AG
2.7.1 F. Hoffmann-La Roche AG Details
2.7.2 F. Hoffmann-La Roche AG Major Business
2.7.3 F. Hoffmann-La Roche AG Opioid Analgesics Product and Services
2.7.4 F. Hoffmann-La Roche AG Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.7.5 F. Hoffmann-La Roche AG Recent Developments/Updates
2.8 Boehringer Ingelheim International GmbH
2.8.1 Boehringer Ingelheim International GmbH Details
2.8.2 Boehringer Ingelheim International GmbH Major Business
2.8.3 Boehringer Ingelheim International GmbH Opioid Analgesics Product and Services
2.8.4 Boehringer Ingelheim International GmbH Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.8.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
2.9 Bausch Health
2.9.1 Bausch Health Details
2.9.2 Bausch Health Major Business
2.9.3 Bausch Health Opioid Analgesics Product and Services
2.9.4 Bausch Health Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.9.5 Bausch Health Recent Developments/Updates
2.10 Sanofi S.A.
2.10.1 Sanofi S.A. Details
2.10.2 Sanofi S.A. Major Business
2.10.3 Sanofi S.A. Opioid Analgesics Product and Services
2.10.4 Sanofi S.A. Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.10.5 Sanofi S.A. Recent Developments/Updates
2.11 Teva Pharmaceuticals
2.11.1 Teva Pharmaceuticals Details
2.11.2 Teva Pharmaceuticals Major Business
2.11.3 Teva Pharmaceuticals Opioid Analgesics Product and Services
2.11.4 Teva Pharmaceuticals Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.11.5 Teva Pharmaceuticals Recent Developments/Updates
2.12 Purdue Pharmaceuticals L.P.
2.12.1 Purdue Pharmaceuticals L.P. Details
2.12.2 Purdue Pharmaceuticals L.P. Major Business
2.12.3 Purdue Pharmaceuticals L.P. Opioid Analgesics Product and Services
2.12.4 Purdue Pharmaceuticals L.P. Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.12.5 Purdue Pharmaceuticals L.P. Recent Developments/Updates
2.13 Endo International Plc
2.13.1 Endo International Plc Details
2.13.2 Endo International Plc Major Business
2.13.3 Endo International Plc Opioid Analgesics Product and Services
2.13.4 Endo International Plc Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.13.5 Endo International Plc Recent Developments/Updates
2.14 Assertio Holdings, Inc
2.14.1 Assertio Holdings, Inc Details
2.14.2 Assertio Holdings, Inc Major Business
2.14.3 Assertio Holdings, Inc Opioid Analgesics Product and Services
2.14.4 Assertio Holdings, Inc Opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.14.5 Assertio Holdings, Inc Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: OPIOID ANALGESICS BY MANUFACTURER
3.1 Global Opioid Analgesics Sales Quantity by Manufacturer (2017-2022)
3.2 Global Opioid Analgesics Revenue by Manufacturer (2017-2022)
3.3 Global Opioid Analgesics Average Price by Manufacturer (2017-2022)
3.4 Market Share Analysis (2021)
3.4.1 Producer Shipments of Opioid Analgesics by Manufacturer Revenue ($MM) and Market Share (%): 2021
3.4.2 Top 3 Opioid Analgesics Manufacturer Market Share in 2021
3.4.2 Top 6 Opioid Analgesics Manufacturer Market Share in 2021
3.5 Opioid Analgesics Market: Overall Company Footprint Analysis
3.5.1 Opioid Analgesics Market: Region Footprint
3.5.2 Opioid Analgesics Market: Company Product Type Footprint
3.5.3 Opioid Analgesics Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Opioid Analgesics Market Size by Region
4.1.1 Global Opioid Analgesics Sales Quantity by Region (2017-2028)
4.1.2 Global Opioid Analgesics Consumption Value by Region (2017-2028)
4.1.3 Global Opioid Analgesics Average Price by Region (2017-2028)
4.2 North America Opioid Analgesics Consumption Value (2017-2028)
4.3 Europe Opioid Analgesics Consumption Value (2017-2028)
4.4 Asia-Pacific Opioid Analgesics Consumption Value (2017-2028)
4.5 South America Opioid Analgesics Consumption Value (2017-2028)
4.6 Middle East and Africa Opioid Analgesics Consumption Value (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global Opioid Analgesics Sales Quantity by Type (2017-2028)
5.2 Global Opioid Analgesics Consumption Value by Type (2017-2028)
5.3 Global Opioid Analgesics Average Price by Type (2017-2028)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Opioid Analgesics Sales Quantity by Application (2017-2028)
6.2 Global Opioid Analgesics Consumption Value by Application (2017-2028)
6.3 Global Opioid Analgesics Average Price by Application (2017-2028)
7 NORTH AMERICA
7.1 North America Opioid Analgesics Sales Quantity by Type (2017-2028)
7.2 North America Opioid Analgesics Sales Quantity by Application (2017-2028)
7.3 North America Opioid Analgesics Market Size by Country
7.3.1 North America Opioid Analgesics Sales Quantity by Country (2017-2028)
7.3.2 North America Opioid Analgesics Consumption Value by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE
8.1 Europe Opioid Analgesics Sales Quantity by Type (2017-2028)
8.2 Europe Opioid Analgesics Sales Quantity by Application (2017-2028)
8.3 Europe Opioid Analgesics Market Size by Country
8.3.1 Europe Opioid Analgesics Sales Quantity by Country (2017-2028)
8.3.2 Europe Opioid Analgesics Consumption Value by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC
9.1 Asia-Pacific Opioid Analgesics Sales Quantity by Type (2017-2028)
9.2 Asia-Pacific Opioid Analgesics Sales Quantity by Application (2017-2028)
9.3 Asia-Pacific Opioid Analgesics Market Size by Region
9.3.1 Asia-Pacific Opioid Analgesics Sales Quantity by Region (2017-2028)
9.3.2 Asia-Pacific Opioid Analgesics Consumption Value by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA
10.1 South America Opioid Analgesics Sales Quantity by Type (2017-2028)
10.2 South America Opioid Analgesics Sales Quantity by Application (2017-2028)
10.3 South America Opioid Analgesics Market Size by Country
10.3.1 South America Opioid Analgesics Sales Quantity by Country (2017-2028)
10.3.2 South America Opioid Analgesics Consumption Value by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Opioid Analgesics Sales Quantity by Type (2017-2028)
11.2 Middle East & Africa Opioid Analgesics Sales Quantity by Application (2017-2028)
11.3 Middle East & Africa Opioid Analgesics Market Size by Country
11.3.1 Middle East & Africa Opioid Analgesics Sales Quantity by Country (2017-2028)
11.3.2 Middle East & Africa Opioid Analgesics Consumption Value by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 MARKET DYNAMICS
12.1 Opioid Analgesics Market Drivers
12.2 Opioid Analgesics Market Restraints
12.3 Opioid Analgesics Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Opioid Analgesics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Opioid Analgesics
13.3 Opioid Analgesics Production Process
13.4 Opioid Analgesics Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Opioid Analgesics Typical Distributors
14.3 Opioid Analgesics Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Opioid Analgesics Consumption Value by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Opioid Analgesics Consumption Value by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Inc. Major Business
Table 5. Pfizer Inc. Opioid Analgesics Product and Services
Table 6. Pfizer Inc. Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 7. Pfizer Inc. Recent Developments/Updates
Table 8. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 9. Abbott Laboratories Major Business
Table 10. Abbott Laboratories Opioid Analgesics Product and Services
Table 11. Abbott Laboratories Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 12. Abbott Laboratories Recent Developments/Updates
Table 13. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 14. Johnson & Johnson Major Business
Table 15. Johnson & Johnson Opioid Analgesics Product and Services
Table 16. Johnson & Johnson Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 17. Johnson & Johnson Recent Developments/Updates
Table 18. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 19. Novartis AG Major Business
Table 20. Novartis AG Opioid Analgesics Product and Services
Table 21. Novartis AG Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 22. Novartis AG Recent Developments/Updates
Table 23. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 24. Bayer AG Major Business
Table 25. Bayer AG Opioid Analgesics Product and Services
Table 26. Bayer AG Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 27. Bayer AG Recent Developments/Updates
Table 28. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 29. GlaxoSmithKline plc Major Business
Table 30. GlaxoSmithKline plc Opioid Analgesics Product and Services
Table 31. GlaxoSmithKline plc Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 32. GlaxoSmithKline plc Recent Developments/Updates
Table 33. F. Hoffmann-La Roche AG Basic Information, Manufacturing Base and Competitors
Table 34. F. Hoffmann-La Roche AG Major Business
Table 35. F. Hoffmann-La Roche AG Opioid Analgesics Product and Services
Table 36. F. Hoffmann-La Roche AG Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 37. F. Hoffmann-La Roche AG Recent Developments/Updates
Table 38. Boehringer Ingelheim International GmbH Basic Information, Manufacturing Base and Competitors
Table 39. Boehringer Ingelheim International GmbH Major Business
Table 40. Boehringer Ingelheim International GmbH Opioid Analgesics Product and Services
Table 41. Boehringer Ingelheim International GmbH Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 42. Boehringer Ingelheim International GmbH Recent Developments/Updates
Table 43. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 44. Bausch Health Major Business
Table 45. Bausch Health Opioid Analgesics Product and Services
Table 46. Bausch Health Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 47. Bausch Health Recent Developments/Updates
Table 48. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 49. Sanofi S.A. Major Business
Table 50. Sanofi S.A. Opioid Analgesics Product and Services
Table 51. Sanofi S.A. Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 52. Sanofi S.A. Recent Developments/Updates
Table 53. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 54. Teva Pharmaceuticals Major Business
Table 55. Teva Pharmaceuticals Opioid Analgesics Product and Services
Table 56. Teva Pharmaceuticals Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 57. Teva Pharmaceuticals Recent Developments/Updates
Table 58. Purdue Pharmaceuticals L.P. Basic Information, Manufacturing Base and Competitors
Table 59. Purdue Pharmaceuticals L.P. Major Business
Table 60. Purdue Pharmaceuticals L.P. Opioid Analgesics Product and Services
Table 61. Purdue Pharmaceuticals L.P. Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 62. Purdue Pharmaceuticals L.P. Recent Developments/Updates
Table 63. Endo International Plc Basic Information, Manufacturing Base and Competitors
Table 64. Endo International Plc Major Business
Table 65. Endo International Plc Opioid Analgesics Product and Services
Table 66. Endo International Plc Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 67. Endo International Plc Recent Developments/Updates
Table 68. Assertio Holdings, Inc Basic Information, Manufacturing Base and Competitors
Table 69. Assertio Holdings, Inc Major Business
Table 70. Assertio Holdings, Inc Opioid Analgesics Product and Services
Table 71. Assertio Holdings, Inc Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 72. Assertio Holdings, Inc Recent Developments/Updates
Table 73. Global Opioid Analgesics Sales Quantity by Manufacturer (2017-2022) & (K Tons)
Table 74. Global Opioid Analgesics Revenue by Manufacturer (2017-2022) & (USD Million)
Table 75. Global Opioid Analgesics Average Price by Manufacturer (2017-2022) & (US$/Ton)
Table 76. Market Position of Manufacturers in Opioid Analgesics, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2021
Table 77. Head Office and Opioid Analgesics Production Site of Key Manufacturer
Table 78. Opioid Analgesics Market: Company Product Type Footprint
Table 79. Opioid Analgesics Market: Company Product Application Footprint
Table 80. Opioid Analgesics New Market Entrants and Barriers to Market Entry
Table 81. Opioid Analgesics Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Opioid Analgesics Sales Quantity by Region (2017-2022) & (K Tons)
Table 83. Global Opioid Analgesics Sales Quantity by Region (2023-2028) & (K Tons)
Table 84. Global Opioid Analgesics Consumption Value by Region (2017-2022) & (USD Million)
Table 85. Global Opioid Analgesics Consumption Value by Region (2023-2028) & (USD Million)
Table 86. Global Opioid Analgesics Average Price by Region (2017-2022) & (US$/Ton)
Table 87. Global Opioid Analgesics Average Price by Region (2023-2028) & (US$/Ton)
Table 88. Global Opioid Analgesics Sales Quantity by Type (2017-2022) & (K Tons)
Table 89. Global Opioid Analgesics Sales Quantity by Type (2023-2028) & (K Tons)
Table 90. Global Opioid Analgesics Consumption Value by Type (2017-2022) & (USD Million)
Table 91. Global Opioid Analgesics Consumption Value by Type (2023-2028) & (USD Million)
Table 92. Global Opioid Analgesics Average Price by Type (2017-2022) & (US$/Ton)
Table 93. Global Opioid Analgesics Average Price by Type (2023-2028) & (US$/Ton)
Table 94. Global Opioid Analgesics Sales Quantity by Application (2017-2022) & (K Tons)
Table 95. Global Opioid Analgesics Sales Quantity by Application (2023-2028) & (K Tons)
Table 96. Global Opioid Analgesics Consumption Value by Application (2017-2022) & (USD Million)
Table 97. Global Opioid Analgesics Consumption Value by Application (2023-2028) & (USD Million)
Table 98. Global Opioid Analgesics Average Price by Application (2017-2022) & (US$/Ton)
Table 99. Global Opioid Analgesics Average Price by Application (2023-2028) & (US$/Ton)
Table 100. North America Opioid Analgesics Sales Quantity by Type (2017-2022) & (K Tons)
Table 101. North America Opioid Analgesics Sales Quantity by Type (2023-2028) & (K Tons)
Table 102. North America Opioid Analgesics Sales Quantity by Application (2017-2022) & (K Tons)
Table 103. North America Opioid Analgesics Sales Quantity by Application (2023-2028) & (K Tons)
Table 104. North America Opioid Analgesics Sales Quantity by Country (2017-2022) & (K Tons)
Table 105. North America Opioid Analgesics Sales Quantity by Country (2023-2028) & (K Tons)
Table 106. North America Opioid Analgesics Consumption Value by Country (2017-2022) & (USD Million)
Table 107. North America Opioid Analgesics Consumption Value by Country (2023-2028) & (USD Million)
Table 108. Europe Opioid Analgesics Sales Quantity by Type (2017-2022) & (K Tons)
Table 109. Europe Opioid Analgesics Sales Quantity by Type (2023-2028) & (K Tons)
Table 110. Europe Opioid Analgesics Sales Quantity by Application (2017-2022) & (K Tons)
Table 111. Europe Opioid Analgesics Sales Quantity by Application (2023-2028) & (K Tons)
Table 112. Europe Opioid Analgesics Sales Quantity by Country (2017-2022) & (K Tons)
Table 113. Europe Opioid Analgesics Sales Quantity by Country (2023-2028) & (K Tons)
Table 114. Europe Opioid Analgesics Consumption Value by Country (2017-2022) & (USD Million)
Table 115. Europe Opioid Analgesics Consumption Value by Country (2023-2028) & (USD Million)
Table 116. Asia-Pacific Opioid Analgesics Sales Quantity by Type (2017-2022) & (K Tons)
Table 117. Asia-Pacific Opioid Analgesics Sales Quantity by Type (2023-2028) & (K Tons)
Table 118. Asia-Pacific Opioid Analgesics Sales Quantity by Application (2017-2022) & (K Tons)
Table 119. Asia-Pacific Opioid Analgesics Sales Quantity by Application (2023-2028) & (K Tons)
Table 120. Asia-Pacific Opioid Analgesics Sales Quantity by Region (2017-2022) & (K Tons)
Table 121. Asia-Pacific Opioid Analgesics Sales Quantity by Region (2023-2028) & (K Tons)
Table 122. Asia-Pacific Opioid Analgesics Consumption Value by Region (2017-2022) & (USD Million)
Table 123. Asia-Pacific Opioid Analgesics Consumption Value by Region (2023-2028) & (USD Million)
Table 124. South America Opioid Analgesics Sales Quantity by Type (2017-2022) & (K Tons)
Table 125. South America Opioid Analgesics Sales Quantity by Type (2023-2028) & (K Tons)
Table 126. South America Opioid Analgesics Sales Quantity by Application (2017-2022) & (K Tons)
Table 127. South America Opioid Analgesics Sales Quantity by Application (2023-2028) & (K Tons)
Table 128. South America Opioid Analgesics Sales Quantity by Country (2017-2022) & (K Tons)
Table 129. South America Opioid Analgesics Sales Quantity by Country (2023-2028) & (K Tons)
Table 130. South America Opioid Analgesics Consumption Value by Country (2017-2022) & (USD Million)
Table 131. South America Opioid Analgesics Consumption Value by Country (2023-2028) & (USD Million)
Table 132. Middle East & Africa Opioid Analgesics Sales Quantity by Type (2017-2022) & (K Tons)
Table 133. Middle East & Africa Opioid Analgesics Sales Quantity by Type (2023-2028) & (K Tons)
Table 134. Middle East & Africa Opioid Analgesics Sales Quantity by Application (2017-2022) & (K Tons)
Table 135. Middle East & Africa Opioid Analgesics Sales Quantity by Application (2023-2028) & (K Tons)
Table 136. Middle East & Africa Opioid Analgesics Sales Quantity by Region (2017-2022) & (K Tons)
Table 137. Middle East & Africa Opioid Analgesics Sales Quantity by Region (2023-2028) & (K Tons)
Table 138. Middle East & Africa Opioid Analgesics Consumption Value by Region (2017-2022) & (USD Million)
Table 139. Middle East & Africa Opioid Analgesics Consumption Value by Region (2023-2028) & (USD Million)
Table 140. Opioid Analgesics Raw Material
Table 141. Key Manufacturers of Opioid Analgesics Raw Materials
Table 142. Opioid Analgesics Typical Distributors
Table 143. Opioid Analgesics Typical Customers
Table 1. Global Opioid Analgesics Consumption Value by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Opioid Analgesics Consumption Value by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Inc. Major Business
Table 5. Pfizer Inc. Opioid Analgesics Product and Services
Table 6. Pfizer Inc. Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 7. Pfizer Inc. Recent Developments/Updates
Table 8. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 9. Abbott Laboratories Major Business
Table 10. Abbott Laboratories Opioid Analgesics Product and Services
Table 11. Abbott Laboratories Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 12. Abbott Laboratories Recent Developments/Updates
Table 13. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 14. Johnson & Johnson Major Business
Table 15. Johnson & Johnson Opioid Analgesics Product and Services
Table 16. Johnson & Johnson Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 17. Johnson & Johnson Recent Developments/Updates
Table 18. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 19. Novartis AG Major Business
Table 20. Novartis AG Opioid Analgesics Product and Services
Table 21. Novartis AG Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 22. Novartis AG Recent Developments/Updates
Table 23. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 24. Bayer AG Major Business
Table 25. Bayer AG Opioid Analgesics Product and Services
Table 26. Bayer AG Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 27. Bayer AG Recent Developments/Updates
Table 28. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 29. GlaxoSmithKline plc Major Business
Table 30. GlaxoSmithKline plc Opioid Analgesics Product and Services
Table 31. GlaxoSmithKline plc Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 32. GlaxoSmithKline plc Recent Developments/Updates
Table 33. F. Hoffmann-La Roche AG Basic Information, Manufacturing Base and Competitors
Table 34. F. Hoffmann-La Roche AG Major Business
Table 35. F. Hoffmann-La Roche AG Opioid Analgesics Product and Services
Table 36. F. Hoffmann-La Roche AG Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 37. F. Hoffmann-La Roche AG Recent Developments/Updates
Table 38. Boehringer Ingelheim International GmbH Basic Information, Manufacturing Base and Competitors
Table 39. Boehringer Ingelheim International GmbH Major Business
Table 40. Boehringer Ingelheim International GmbH Opioid Analgesics Product and Services
Table 41. Boehringer Ingelheim International GmbH Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 42. Boehringer Ingelheim International GmbH Recent Developments/Updates
Table 43. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 44. Bausch Health Major Business
Table 45. Bausch Health Opioid Analgesics Product and Services
Table 46. Bausch Health Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 47. Bausch Health Recent Developments/Updates
Table 48. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 49. Sanofi S.A. Major Business
Table 50. Sanofi S.A. Opioid Analgesics Product and Services
Table 51. Sanofi S.A. Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 52. Sanofi S.A. Recent Developments/Updates
Table 53. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 54. Teva Pharmaceuticals Major Business
Table 55. Teva Pharmaceuticals Opioid Analgesics Product and Services
Table 56. Teva Pharmaceuticals Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 57. Teva Pharmaceuticals Recent Developments/Updates
Table 58. Purdue Pharmaceuticals L.P. Basic Information, Manufacturing Base and Competitors
Table 59. Purdue Pharmaceuticals L.P. Major Business
Table 60. Purdue Pharmaceuticals L.P. Opioid Analgesics Product and Services
Table 61. Purdue Pharmaceuticals L.P. Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 62. Purdue Pharmaceuticals L.P. Recent Developments/Updates
Table 63. Endo International Plc Basic Information, Manufacturing Base and Competitors
Table 64. Endo International Plc Major Business
Table 65. Endo International Plc Opioid Analgesics Product and Services
Table 66. Endo International Plc Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 67. Endo International Plc Recent Developments/Updates
Table 68. Assertio Holdings, Inc Basic Information, Manufacturing Base and Competitors
Table 69. Assertio Holdings, Inc Major Business
Table 70. Assertio Holdings, Inc Opioid Analgesics Product and Services
Table 71. Assertio Holdings, Inc Opioid Analgesics Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 72. Assertio Holdings, Inc Recent Developments/Updates
Table 73. Global Opioid Analgesics Sales Quantity by Manufacturer (2017-2022) & (K Tons)
Table 74. Global Opioid Analgesics Revenue by Manufacturer (2017-2022) & (USD Million)
Table 75. Global Opioid Analgesics Average Price by Manufacturer (2017-2022) & (US$/Ton)
Table 76. Market Position of Manufacturers in Opioid Analgesics, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2021
Table 77. Head Office and Opioid Analgesics Production Site of Key Manufacturer
Table 78. Opioid Analgesics Market: Company Product Type Footprint
Table 79. Opioid Analgesics Market: Company Product Application Footprint
Table 80. Opioid Analgesics New Market Entrants and Barriers to Market Entry
Table 81. Opioid Analgesics Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Opioid Analgesics Sales Quantity by Region (2017-2022) & (K Tons)
Table 83. Global Opioid Analgesics Sales Quantity by Region (2023-2028) & (K Tons)
Table 84. Global Opioid Analgesics Consumption Value by Region (2017-2022) & (USD Million)
Table 85. Global Opioid Analgesics Consumption Value by Region (2023-2028) & (USD Million)
Table 86. Global Opioid Analgesics Average Price by Region (2017-2022) & (US$/Ton)
Table 87. Global Opioid Analgesics Average Price by Region (2023-2028) & (US$/Ton)
Table 88. Global Opioid Analgesics Sales Quantity by Type (2017-2022) & (K Tons)
Table 89. Global Opioid Analgesics Sales Quantity by Type (2023-2028) & (K Tons)
Table 90. Global Opioid Analgesics Consumption Value by Type (2017-2022) & (USD Million)
Table 91. Global Opioid Analgesics Consumption Value by Type (2023-2028) & (USD Million)
Table 92. Global Opioid Analgesics Average Price by Type (2017-2022) & (US$/Ton)
Table 93. Global Opioid Analgesics Average Price by Type (2023-2028) & (US$/Ton)
Table 94. Global Opioid Analgesics Sales Quantity by Application (2017-2022) & (K Tons)
Table 95. Global Opioid Analgesics Sales Quantity by Application (2023-2028) & (K Tons)
Table 96. Global Opioid Analgesics Consumption Value by Application (2017-2022) & (USD Million)
Table 97. Global Opioid Analgesics Consumption Value by Application (2023-2028) & (USD Million)
Table 98. Global Opioid Analgesics Average Price by Application (2017-2022) & (US$/Ton)
Table 99. Global Opioid Analgesics Average Price by Application (2023-2028) & (US$/Ton)
Table 100. North America Opioid Analgesics Sales Quantity by Type (2017-2022) & (K Tons)
Table 101. North America Opioid Analgesics Sales Quantity by Type (2023-2028) & (K Tons)
Table 102. North America Opioid Analgesics Sales Quantity by Application (2017-2022) & (K Tons)
Table 103. North America Opioid Analgesics Sales Quantity by Application (2023-2028) & (K Tons)
Table 104. North America Opioid Analgesics Sales Quantity by Country (2017-2022) & (K Tons)
Table 105. North America Opioid Analgesics Sales Quantity by Country (2023-2028) & (K Tons)
Table 106. North America Opioid Analgesics Consumption Value by Country (2017-2022) & (USD Million)
Table 107. North America Opioid Analgesics Consumption Value by Country (2023-2028) & (USD Million)
Table 108. Europe Opioid Analgesics Sales Quantity by Type (2017-2022) & (K Tons)
Table 109. Europe Opioid Analgesics Sales Quantity by Type (2023-2028) & (K Tons)
Table 110. Europe Opioid Analgesics Sales Quantity by Application (2017-2022) & (K Tons)
Table 111. Europe Opioid Analgesics Sales Quantity by Application (2023-2028) & (K Tons)
Table 112. Europe Opioid Analgesics Sales Quantity by Country (2017-2022) & (K Tons)
Table 113. Europe Opioid Analgesics Sales Quantity by Country (2023-2028) & (K Tons)
Table 114. Europe Opioid Analgesics Consumption Value by Country (2017-2022) & (USD Million)
Table 115. Europe Opioid Analgesics Consumption Value by Country (2023-2028) & (USD Million)
Table 116. Asia-Pacific Opioid Analgesics Sales Quantity by Type (2017-2022) & (K Tons)
Table 117. Asia-Pacific Opioid Analgesics Sales Quantity by Type (2023-2028) & (K Tons)
Table 118. Asia-Pacific Opioid Analgesics Sales Quantity by Application (2017-2022) & (K Tons)
Table 119. Asia-Pacific Opioid Analgesics Sales Quantity by Application (2023-2028) & (K Tons)
Table 120. Asia-Pacific Opioid Analgesics Sales Quantity by Region (2017-2022) & (K Tons)
Table 121. Asia-Pacific Opioid Analgesics Sales Quantity by Region (2023-2028) & (K Tons)
Table 122. Asia-Pacific Opioid Analgesics Consumption Value by Region (2017-2022) & (USD Million)
Table 123. Asia-Pacific Opioid Analgesics Consumption Value by Region (2023-2028) & (USD Million)
Table 124. South America Opioid Analgesics Sales Quantity by Type (2017-2022) & (K Tons)
Table 125. South America Opioid Analgesics Sales Quantity by Type (2023-2028) & (K Tons)
Table 126. South America Opioid Analgesics Sales Quantity by Application (2017-2022) & (K Tons)
Table 127. South America Opioid Analgesics Sales Quantity by Application (2023-2028) & (K Tons)
Table 128. South America Opioid Analgesics Sales Quantity by Country (2017-2022) & (K Tons)
Table 129. South America Opioid Analgesics Sales Quantity by Country (2023-2028) & (K Tons)
Table 130. South America Opioid Analgesics Consumption Value by Country (2017-2022) & (USD Million)
Table 131. South America Opioid Analgesics Consumption Value by Country (2023-2028) & (USD Million)
Table 132. Middle East & Africa Opioid Analgesics Sales Quantity by Type (2017-2022) & (K Tons)
Table 133. Middle East & Africa Opioid Analgesics Sales Quantity by Type (2023-2028) & (K Tons)
Table 134. Middle East & Africa Opioid Analgesics Sales Quantity by Application (2017-2022) & (K Tons)
Table 135. Middle East & Africa Opioid Analgesics Sales Quantity by Application (2023-2028) & (K Tons)
Table 136. Middle East & Africa Opioid Analgesics Sales Quantity by Region (2017-2022) & (K Tons)
Table 137. Middle East & Africa Opioid Analgesics Sales Quantity by Region (2023-2028) & (K Tons)
Table 138. Middle East & Africa Opioid Analgesics Consumption Value by Region (2017-2022) & (USD Million)
Table 139. Middle East & Africa Opioid Analgesics Consumption Value by Region (2023-2028) & (USD Million)
Table 140. Opioid Analgesics Raw Material
Table 141. Key Manufacturers of Opioid Analgesics Raw Materials
Table 142. Opioid Analgesics Typical Distributors
Table 143. Opioid Analgesics Typical Customers
LIST OF FIGURES
s
Figure 1. Opioid Analgesics Picture
Figure 2. Global Opioid Analgesics Consumption Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 3. Global Opioid Analgesics Consumption Value Market Share by Type in 2021
Figure 4. OxyContin Examples
Figure 5. Vicodin Examples
Figure 6. Morphine Examples
Figure 7. Methadone Examples
Figure 8. Others Examples
Figure 9. Global Opioid Analgesics Consumption Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 10. Global Opioid Analgesics Consumption Value Market Share by Application in 2021
Figure 11. Surgical Pain Examples
Figure 12. Cancer Pain Examples
Figure 13. Neuropathic Pain Examples
Figure 14. Others Examples
Figure 15. Global Opioid Analgesics Consumption Value, (USD Million): 2017 & 2021 & 2028
Figure 16. Global Opioid Analgesics Consumption Value and Forecast (2017-2028) & (USD Million)
Figure 17. Global Opioid Analgesics Sales Quantity (2017-2028) & (K Tons)
Figure 18. Global Opioid Analgesics Average Price (2017-2028) & (US$/Ton)
Figure 19. Global Opioid Analgesics Sales Quantity Market Share by Manufacturer in 2021
Figure 20. Global Opioid Analgesics Consumption Value Market Share by Manufacturer in 2021
Figure 21. Producer Shipments of Opioid Analgesics by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Opioid Analgesics Manufacturer (Consumption Value) Market Share in 2021
Figure 23. Top 6 Opioid Analgesics Manufacturer (Consumption Value) Market Share in 2021
Figure 24. Global Opioid Analgesics Sales Quantity Market Share by Region (2017-2028)
Figure 25. Global Opioid Analgesics Consumption Value Market Share by Region (2017-2028)
Figure 26. North America Opioid Analgesics Consumption Value (2017-2028) & (USD Million)
Figure 27. Europe Opioid Analgesics Consumption Value (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Opioid Analgesics Consumption Value (2017-2028) & (USD Million)
Figure 29. South America Opioid Analgesics Consumption Value (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Opioid Analgesics Consumption Value (2017-2028) & (USD Million)
Figure 31. Global Opioid Analgesics Sales Quantity Market Share by Type (2017-2028)
Figure 32. Global Opioid Analgesics Consumption Value Market Share by Type (2017-2028)
Figure 33. Global Opioid Analgesics Average Price by Type (2017-2028) & (US$/Ton)
Figure 34. Global Opioid Analgesics Sales Quantity Market Share by Application (2017-2028)
Figure 35. Global Opioid Analgesics Consumption Value Market Share by Application (2017-2028)
Figure 36. Global Opioid Analgesics Average Price by Application (2017-2028) & (US$/Ton)
Figure 37. North America Opioid Analgesics Sales Quantity Market Share by Type (2017-2028)
Figure 38. North America Opioid Analgesics Sales Quantity Market Share by Application (2017-2028)
Figure 39. North America Opioid Analgesics Sales Quantity Market Share by Country (2017-2028)
Figure 40. North America Opioid Analgesics Consumption Value Market Share by Country (2017-2028)
Figure 41. United States Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Opioid Analgesics Sales Quantity Market Share by Type (2017-2028)
Figure 45. Europe Opioid Analgesics Sales Quantity Market Share by Application (2017-2028)
Figure 46. Europe Opioid Analgesics Sales Quantity Market Share by Country (2017-2028)
Figure 47. Europe Opioid Analgesics Consumption Value Market Share by Country (2017-2028)
Figure 48. Germany Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Opioid Analgesics Sales Quantity Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Opioid Analgesics Sales Quantity Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Opioid Analgesics Sales Quantity Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Opioid Analgesics Consumption Value Market Share by Region (2017-2028)
Figure 57. China Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Opioid Analgesics Sales Quantity Market Share by Type (2017-2028)
Figure 64. South America Opioid Analgesics Sales Quantity Market Share by Application (2017-2028)
Figure 65. South America Opioid Analgesics Sales Quantity Market Share by Country (2017-2028)
Figure 66. South America Opioid Analgesics Consumption Value Market Share by Country (2017-2028)
Figure 67. Brazil Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Opioid Analgesics Sales Quantity Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Opioid Analgesics Sales Quantity Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Opioid Analgesics Sales Quantity Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Opioid Analgesics Consumption Value Market Share by Region (2017-2028)
Figure 73. Turkey Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 77. Opioid Analgesics Market Drivers
Figure 78. Opioid Analgesics Market Restraints
Figure 79. Opioid Analgesics Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Opioid Analgesics in 2021
Figure 82. Manufacturing Process Analysis of Opioid Analgesics
Figure 83. Opioid Analgesics Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
s
Figure 1. Opioid Analgesics Picture
Figure 2. Global Opioid Analgesics Consumption Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 3. Global Opioid Analgesics Consumption Value Market Share by Type in 2021
Figure 4. OxyContin Examples
Figure 5. Vicodin Examples
Figure 6. Morphine Examples
Figure 7. Methadone Examples
Figure 8. Others Examples
Figure 9. Global Opioid Analgesics Consumption Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 10. Global Opioid Analgesics Consumption Value Market Share by Application in 2021
Figure 11. Surgical Pain Examples
Figure 12. Cancer Pain Examples
Figure 13. Neuropathic Pain Examples
Figure 14. Others Examples
Figure 15. Global Opioid Analgesics Consumption Value, (USD Million): 2017 & 2021 & 2028
Figure 16. Global Opioid Analgesics Consumption Value and Forecast (2017-2028) & (USD Million)
Figure 17. Global Opioid Analgesics Sales Quantity (2017-2028) & (K Tons)
Figure 18. Global Opioid Analgesics Average Price (2017-2028) & (US$/Ton)
Figure 19. Global Opioid Analgesics Sales Quantity Market Share by Manufacturer in 2021
Figure 20. Global Opioid Analgesics Consumption Value Market Share by Manufacturer in 2021
Figure 21. Producer Shipments of Opioid Analgesics by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Opioid Analgesics Manufacturer (Consumption Value) Market Share in 2021
Figure 23. Top 6 Opioid Analgesics Manufacturer (Consumption Value) Market Share in 2021
Figure 24. Global Opioid Analgesics Sales Quantity Market Share by Region (2017-2028)
Figure 25. Global Opioid Analgesics Consumption Value Market Share by Region (2017-2028)
Figure 26. North America Opioid Analgesics Consumption Value (2017-2028) & (USD Million)
Figure 27. Europe Opioid Analgesics Consumption Value (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Opioid Analgesics Consumption Value (2017-2028) & (USD Million)
Figure 29. South America Opioid Analgesics Consumption Value (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Opioid Analgesics Consumption Value (2017-2028) & (USD Million)
Figure 31. Global Opioid Analgesics Sales Quantity Market Share by Type (2017-2028)
Figure 32. Global Opioid Analgesics Consumption Value Market Share by Type (2017-2028)
Figure 33. Global Opioid Analgesics Average Price by Type (2017-2028) & (US$/Ton)
Figure 34. Global Opioid Analgesics Sales Quantity Market Share by Application (2017-2028)
Figure 35. Global Opioid Analgesics Consumption Value Market Share by Application (2017-2028)
Figure 36. Global Opioid Analgesics Average Price by Application (2017-2028) & (US$/Ton)
Figure 37. North America Opioid Analgesics Sales Quantity Market Share by Type (2017-2028)
Figure 38. North America Opioid Analgesics Sales Quantity Market Share by Application (2017-2028)
Figure 39. North America Opioid Analgesics Sales Quantity Market Share by Country (2017-2028)
Figure 40. North America Opioid Analgesics Consumption Value Market Share by Country (2017-2028)
Figure 41. United States Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Opioid Analgesics Sales Quantity Market Share by Type (2017-2028)
Figure 45. Europe Opioid Analgesics Sales Quantity Market Share by Application (2017-2028)
Figure 46. Europe Opioid Analgesics Sales Quantity Market Share by Country (2017-2028)
Figure 47. Europe Opioid Analgesics Consumption Value Market Share by Country (2017-2028)
Figure 48. Germany Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Opioid Analgesics Sales Quantity Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Opioid Analgesics Sales Quantity Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Opioid Analgesics Sales Quantity Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Opioid Analgesics Consumption Value Market Share by Region (2017-2028)
Figure 57. China Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Opioid Analgesics Sales Quantity Market Share by Type (2017-2028)
Figure 64. South America Opioid Analgesics Sales Quantity Market Share by Application (2017-2028)
Figure 65. South America Opioid Analgesics Sales Quantity Market Share by Country (2017-2028)
Figure 66. South America Opioid Analgesics Consumption Value Market Share by Country (2017-2028)
Figure 67. Brazil Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Opioid Analgesics Sales Quantity Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Opioid Analgesics Sales Quantity Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Opioid Analgesics Sales Quantity Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Opioid Analgesics Consumption Value Market Share by Region (2017-2028)
Figure 73. Turkey Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 77. Opioid Analgesics Market Drivers
Figure 78. Opioid Analgesics Market Restraints
Figure 79. Opioid Analgesics Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Opioid Analgesics in 2021
Figure 82. Manufacturing Process Analysis of Opioid Analgesics
Figure 83. Opioid Analgesics Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
